Lydus Medical develops the Vesseal™, an automated microvascular suturing device designed for the anastomosis of small blood vessels ranging from 0.5 to 4 mm. This technology reduces ischemic time and operating room duration while enhancing procedural safety and efficiency in cardiovascular, transplant, and reconstructive microsurgery.
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Microvascular anastomosis, the joining of small blood vessels, is a critical but challenging aspect of cardiovascular, transplant, and reconstructive microsurgery. The manual suturing process demands high dexterity, has a steep learning curve, and can lead to suboptimal ischemic time, post-procedure complications, and prolonged operating room time.
Solution
Lydus Medical's Vesseal™ is an automated microvascular suturing device designed to simplify and standardize the anastomosis of blood and lymph vessels ranging from 0.5 to 4mm. The device delivers thread-only sutures to enable simple, fast, easy, safe, and effective procedures. By automating the suturing process, Vesseal™ aims to decrease ischemia and operating room time while enhancing procedural safety and efficiency. The technology is designed to be suitable for various surgical settings, including remote, robotic, and laparoscopic procedures.
Target Audience
The primary target audience includes cardiovascular surgeons, transplant surgeons, reconstructive microsurgeons, and other medical professionals performing microvascular anastomosis procedures.
Features
- Automated microvascular suturing for vessels 0.5-4mm in diameter
- Suitable for both blood and lymph vessels
- Designed for ease of use and intuitive operation
- Aims to decrease ischemia and operating room time
- Thread-only suturing, leaving no device components implanted
- Compatible with robotic and laparoscopic surgical platforms